Comprehensive Characterization and Contribution of the Keratinocytes-Fibroblasts Crosstalk in 3D-Scleroderma Skin Equivalent

Project: Research project

Project Details

StatusActive
Effective start/end date3/13/203/13/23

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (STU#00209096)